Please provide your email address to receive an email when new articles are posted on . Combining motivational interviews with cognitive behavioral therapy improved negative symptoms of schizophrenia ...

UCSF researcher Daniel Mathalon, MD, PhD, believes that burgeoning knowledge about biomarkers — biological measures of a ...

Antipsychotic medicines are a key part of the pharmacological treatment of schizophrenia. Although they provide therapeutic ...

Findings reinforce brilaroxazine’s treatment effect on negative symptoms and other symptom domains in schizophrenia and support clinician-assessed efficacy outcomes in a Phase 3 trial of brilaroxazine ...

Schizophrenia is a chronic psychiatric disorder that requires lifelong management, with consistent medication adherence essential to prevent relapse and disability. Counseling that emphasizes empathy, ...

A simple cheek swab could one day provide a quick and noninvasive diagnostic test for schizophrenia. A new study published in ...

Schizophrenia drugs mainly go after the same target in the brain, but drug developers are hoping to improve on the efficacy and side effect profile of such medicines by going after new targets. The ...